机构:[1]Department of Nephrology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health,Beijing Key Laboratory of Pediatric Chronic Kidney Disease and Blood Purification, Key Laboratory ofMajor Diseases in Children, Ministry of Education, Beijing 100045临床科室科研平台职能科室儿童慢病管理中心临床流行病与循证医学中心肾脏科首都医科大学附属北京儿童医院[2]Pediatric Department, Shunyi Women'sand Children's Hospital of Beijing Children's Hospital, Beijing 101300, P.R. China首都医科大学附属北京儿童医院
The aim of the present study was to investigate the effect of microRNAs (miRNAs) on the expression level of core1β3‑galactosyltransferase‑specific molecular chaperone (COSMC) in immunoglobulin A nephropathy (IgAN). miRNA expression levels were determined in pediatric patients with IgAN (IgAN group), in patients with other renal diseases (control group) and healthy pediatrics (control group). The target miRNAs of COSMC were investigated in the present study. Western blot analysis was performed to examine the effects of miRNAs on COSMC expression levels. In addition, galactose‑deficient IgA1 (Gd‑IgA1) expression levels were detected following the addition of miRNA‑196b. The present results suggested that the expression levels of 205 miRNAs significantly differed between the IgAN and healthy control groups. The present results also suggested that miRNA‑196b and miRNA‑33a‑3p targeted COSMC, and that miRNA‑196b expression in B lymphocytes was significantly higher in the IgAN group compared with the control group (P<0.0001). However, COSMC expression level was significantly downregulated in isolated B lymphocytes transfected with miRNA‑196b mimics, but Gd‑IgA1 expression levels were increased. Therefore, miRNA‑196b may play a role in the formation of Gd‑IgA1 and IgAN pathogenesis via COSMC regulation.
基金:
national natural Science Fund (grant no. 81600551), the Beijing Municipal Science and Technology commission Major research Project (grant no. d181100000118006), the capital Health research and development of Special Grant (grant no. 2016-2-2094) and the application of capital clinical characteristics Program of Beijing Municipal Science and Technology commission (grant no. Z161100000516106).
第一作者机构:[1]Department of Nephrology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health,Beijing Key Laboratory of Pediatric Chronic Kidney Disease and Blood Purification, Key Laboratory ofMajor Diseases in Children, Ministry of Education, Beijing 100045
通讯作者:
通讯机构:[1]Department of Nephrology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health,Beijing Key Laboratory of Pediatric Chronic Kidney Disease and Blood Purification, Key Laboratory ofMajor Diseases in Children, Ministry of Education, Beijing 100045[*1]Department of Nephrology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing Key Laboratory of Pediatric Chronic Kidney Disease and Blood Purification, Key Laboratory of Major Diseases in Children, Ministry of Education, 56 Nanlishi Road, Beijing 100045, P.R. China
推荐引用方式(GB/T 7714):
QIANG SUN,JINGCHAO LAN,HONG ZHANG,et al.MicroRNA‑196b targets COSMC in pediatric IgA nephropathy.[J].Molecular medicine reports.2020,21(5):2260-2266.doi:10.3892/mmr.2020.11015.
APA:
QIANG SUN,JINGCHAO LAN,HONG ZHANG,NAN ZHOU,YING LIANG&XIAORONG LIU.(2020).MicroRNA‑196b targets COSMC in pediatric IgA nephropathy..Molecular medicine reports,21,(5)
MLA:
QIANG SUN,et al."MicroRNA‑196b targets COSMC in pediatric IgA nephropathy.".Molecular medicine reports 21..5(2020):2260-2266